A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma

脂多糖学 临床化学 淋巴瘤 弥漫性大B细胞淋巴瘤 临床营养学 脂质代谢 医学 新陈代谢 癌症研究 生物 计算生物学 免疫学 内科学
作者
Zhao-Li Zhang,Chong Zhao,Shaoxin Yang,Wei Lu,Jun Shi
出处
期刊:Lipids in Health and Disease [BioMed Central]
卷期号:23 (1) 被引量:1
标识
DOI:10.1186/s12944-024-02017-z
摘要

Abstract Background The molecular diversity exhibited by diffuse large B-cell lymphoma (DLBCL) is a significant obstacle facing current precision therapies. However, scoring using the International Prognostic Index (IPI) is inadequate when fully predicting the development of DLBCL. Reprogramming lipid metabolism is crucial for DLBCL carcinogenesis and expansion, while a predictive approach derived from lipid metabolism-associated genes (LMAGs) has not yet been recognized for DLBCL. Methods Gene expression profiles of DLBCL were generated using the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. The LASSO Cox regression was used to construct an effective predictive risk-scoring model for DLBCL patients. The Kaplan-Meier survival assessment was employed to compare a given risk score with the IPI score and its impact on the survival of DLBCL patients. Functional enrichment examination was performed utilizing the KEGG pathway. After identifying hub genes via single-sample GSEA (ssGSEA), immunohistochemical staining and immunofluorescence were performed on lymph node samples from control and DLBCL patients to confirm these identified genes. Results Sixteen lipid metabolism- and survival-associated genes were identified to construct a prognostic risk-scoring approach. This model demonstrated robust performance over various datasets and emerged as an autonomous risk factor for predicting the development of DLBCL patients. The risk score could significantly distinguish the development of DLBCL patients from the low-risk and elevated-risk IPI classes. Results from the inhibitory immune-related pathways and lower immune scores suggested an immunosuppressive phenotype within the elevated-risk group. Three hub genes, MECR , ARSK , and RAN , were identified to be negatively correlated with activated CD8 T cells and natural killer T cells in the elevated-risk score class. Ultimately, it was determined that these three genes were expressed by lymphoma cells but not by T cells in clinical samples from DLBCL patients. Conclusion The risk level model derived from 16 lipid metabolism-associated genes represents a prognostic biomarker for DLBCL that is novel, robust, and may have an immunosuppressive role. It can compensate for the limitations of the IPI score in predicting overall survival and has potential clinical application value.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
吃饭打肯德基完成签到 ,获得积分10
2秒前
Passerby完成签到,获得积分10
3秒前
zxdw完成签到,获得积分10
3秒前
4秒前
零一发布了新的文献求助10
4秒前
奖品肉麻膏耶完成签到 ,获得积分10
4秒前
李昭进完成签到,获得积分10
5秒前
hvtu完成签到 ,获得积分10
6秒前
6秒前
7秒前
凌风发布了新的文献求助10
7秒前
zheng完成签到 ,获得积分10
8秒前
牛牛牛完成签到,获得积分10
8秒前
在水一方的应助被purplish采纳,获得10
8秒前
一九完成签到 ,获得积分10
8秒前
科研渣渣发布了新的文献求助10
8秒前
luoluo完成签到,获得积分10
8秒前
闵不悔完成签到,获得积分10
9秒前
威武如柏完成签到,获得积分10
9秒前
10秒前
欢喜的冰双完成签到,获得积分10
10秒前
苏轼完成签到,获得积分10
11秒前
谷雷努的应助被Ying采纳,获得10
12秒前
谷雷努的应助被Ying采纳,获得10
12秒前
Jane发布了新的文献求助10
12秒前
yyh完成签到 ,获得积分10
13秒前
tansl1989完成签到,获得积分20
13秒前
兔子星星完成签到,获得积分10
14秒前
科研通AI2S的应助被luoluo采纳,获得10
15秒前
zddecho发布了新的文献求助10
16秒前
做五次缩肛运动完成签到,获得积分10
16秒前
家若发布了新的文献求助50
17秒前
Sheep完成签到 ,获得积分10
18秒前
朱瞻基完成签到,获得积分10
19秒前
king_creole完成签到,获得积分10
19秒前
斯文败类的应助被你好采纳,获得10
19秒前
20秒前
找找发布了新的文献求助10
20秒前
我真是坠了完成签到,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185743
求助须知:如何正确求助?哪些是违规求助? 9574397
关于积分的说明 21836038
捐赠科研通 7783520
什么是DOI,文献DOI怎么找? 3434643
关于科研通互助平台的介绍 2559017
邀请新用户注册赠送积分活动 2481440